vs

Side-by-side financial comparison of CuriosityStream Inc. (CURI) and PARK AEROSPACE CORP (PKE). Click either name above to swap in a different company.

CuriosityStream Inc. is the larger business by last-quarter revenue ($19.2M vs $17.3M, roughly 1.1× PARK AEROSPACE CORP). PARK AEROSPACE CORP runs the higher net margin — 17.0% vs -19.7%, a 36.7% gap on every dollar of revenue. On growth, CuriosityStream Inc. posted the faster year-over-year revenue change (35.8% vs 20.3%). PARK AEROSPACE CORP produced more free cash flow last quarter ($4.3M vs $3.9M). Over the past eight quarters, CuriosityStream Inc.'s revenue compounded faster (26.5% CAGR vs 3.0%).

Curiosity Stream Inc., formerly branded as CuriosityStream, is an American media company and over-the-top subscription video streaming service which offers documentary programming including films, series, and TV shows. The company offers a video on demand subscription service branded as "Curiosity Stream" and a linear broadcast television channel known as the Curiosity Channel through various services including FuboTV and The Roku Channel.

Park Electrochemical Corp, now called the Park Aerospace Corp, is a Melville, New York-based materials manufacturer for the telecommunications, Internet infrastructure, high-end computing, and aerospace industries. It produces high-technology digital and radio frequency(RF)/microwave printed circuit material products, composite materials. Its printed circuit materials are used for complex multilayer printed circuit boards and other electronic interconnection systems, such as multilayer back-p...

CURI vs PKE — Head-to-Head

Bigger by revenue
CURI
CURI
1.1× larger
CURI
$19.2M
$17.3M
PKE
Growing faster (revenue YoY)
CURI
CURI
+15.5% gap
CURI
35.8%
20.3%
PKE
Higher net margin
PKE
PKE
36.7% more per $
PKE
17.0%
-19.7%
CURI
More free cash flow
PKE
PKE
$326.0K more FCF
PKE
$4.3M
$3.9M
CURI
Faster 2-yr revenue CAGR
CURI
CURI
Annualised
CURI
26.5%
3.0%
PKE

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
CURI
CURI
PKE
PKE
Revenue
$19.2M
$17.3M
Net Profit
$-3.8M
$3.0M
Gross Margin
34.1%
Operating Margin
-17.6%
21.0%
Net Margin
-19.7%
17.0%
Revenue YoY
35.8%
20.3%
Net Profit YoY
-34.6%
87.1%
EPS (diluted)
$-0.07
$0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CURI
CURI
PKE
PKE
Q4 25
$19.2M
$17.3M
Q3 25
$18.4M
$16.4M
Q2 25
$19.0M
$15.4M
Q1 25
$15.1M
$16.9M
Q4 24
$14.1M
$14.4M
Q3 24
$12.6M
$16.7M
Q2 24
$12.4M
$14.0M
Q1 24
$12.0M
$16.3M
Net Profit
CURI
CURI
PKE
PKE
Q4 25
$-3.8M
$3.0M
Q3 25
$-3.7M
$2.4M
Q2 25
$784.0K
$2.1M
Q1 25
$319.0K
$1.2M
Q4 24
$-2.8M
$1.6M
Q3 24
$-3.1M
$2.1M
Q2 24
$-2.0M
$993.0K
Q1 24
$-5.0M
$2.7M
Gross Margin
CURI
CURI
PKE
PKE
Q4 25
34.1%
Q3 25
31.2%
Q2 25
30.6%
Q1 25
29.3%
Q4 24
26.6%
Q3 24
28.5%
Q2 24
29.3%
Q1 24
27.3%
Operating Margin
CURI
CURI
PKE
PKE
Q4 25
-17.6%
21.0%
Q3 25
-24.5%
17.4%
Q2 25
2.5%
15.7%
Q1 25
0.5%
16.8%
Q4 24
-27.4%
12.8%
Q3 24
-25.8%
15.7%
Q2 24
-20.6%
14.9%
Q1 24
-30.4%
15.7%
Net Margin
CURI
CURI
PKE
PKE
Q4 25
-19.7%
17.0%
Q3 25
-20.4%
14.7%
Q2 25
4.1%
13.5%
Q1 25
2.1%
7.4%
Q4 24
-19.9%
10.9%
Q3 24
-24.3%
12.4%
Q2 24
-16.4%
7.1%
Q1 24
-42.0%
16.3%
EPS (diluted)
CURI
CURI
PKE
PKE
Q4 25
$-0.07
$0.15
Q3 25
$-0.06
$0.12
Q2 25
$0.01
$0.10
Q1 25
$0.01
$0.06
Q4 24
$-0.05
$0.08
Q3 24
$-0.06
$0.10
Q2 24
$-0.04
$0.05
Q1 24
$-0.09
$0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CURI
CURI
PKE
PKE
Cash + ST InvestmentsLiquidity on hand
$27.3M
$63.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$41.5M
$106.6M
Total Assets
$75.7M
$118.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CURI
CURI
PKE
PKE
Q4 25
$27.3M
$63.6M
Q3 25
$27.8M
$61.6M
Q2 25
$28.1M
$65.6M
Q1 25
$33.4M
$68.8M
Q4 24
$32.1M
$70.0M
Q3 24
$33.2M
$72.0M
Q2 24
$39.5M
$74.4M
Q1 24
$38.8M
$77.2M
Stockholders' Equity
CURI
CURI
PKE
PKE
Q4 25
$41.5M
$106.6M
Q3 25
$47.2M
$105.8M
Q2 25
$49.8M
$105.0M
Q1 25
$58.1M
$107.2M
Q4 24
$57.8M
$107.4M
Q3 24
$62.2M
$110.3M
Q2 24
$64.8M
$111.7M
Q1 24
$67.0M
$112.9M
Total Assets
CURI
CURI
PKE
PKE
Q4 25
$75.7M
$118.1M
Q3 25
$74.7M
$116.4M
Q2 25
$78.7M
$120.7M
Q1 25
$85.3M
$122.1M
Q4 24
$86.2M
$124.2M
Q3 24
$87.6M
$125.1M
Q2 24
$90.9M
$129.4M
Q1 24
$94.6M
$132.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CURI
CURI
PKE
PKE
Operating Cash FlowLast quarter
$4.0M
$5.1M
Free Cash FlowOCF − Capex
$3.9M
$4.3M
FCF MarginFCF / Revenue
20.5%
24.6%
Capex IntensityCapex / Revenue
0.1%
4.8%
Cash ConversionOCF / Net Profit
1.73×
TTM Free Cash FlowTrailing 4 quarters
$3.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CURI
CURI
PKE
PKE
Q4 25
$4.0M
$5.1M
Q3 25
$4.4M
$-2.1M
Q2 25
$2.8M
$1.6M
Q1 25
$1.9M
$969.0K
Q4 24
$3.0M
$2.7M
Q3 24
$2.3M
$1.4M
Q2 24
$2.2M
$-423.0K
Q1 24
$666.0K
$5.3M
Free Cash Flow
CURI
CURI
PKE
PKE
Q4 25
$3.9M
$4.3M
Q3 25
$-2.3M
Q2 25
$1.1M
Q1 25
$1.8M
$338.0K
Q4 24
$2.7M
Q3 24
$1.3M
Q2 24
$-435.0K
Q1 24
$5.1M
FCF Margin
CURI
CURI
PKE
PKE
Q4 25
20.5%
24.6%
Q3 25
-14.0%
Q2 25
7.2%
Q1 25
12.2%
2.0%
Q4 24
18.6%
Q3 24
7.5%
Q2 24
-3.1%
Q1 24
31.4%
Capex Intensity
CURI
CURI
PKE
PKE
Q4 25
0.1%
4.8%
Q3 25
0.0%
1.1%
Q2 25
0.0%
3.1%
Q1 25
0.5%
3.7%
Q4 24
0.0%
0.4%
Q3 24
0.0%
1.2%
Q2 24
0.0%
0.1%
Q1 24
0.0%
1.0%
Cash Conversion
CURI
CURI
PKE
PKE
Q4 25
1.73×
Q3 25
-0.88×
Q2 25
3.56×
0.76×
Q1 25
6.03×
0.78×
Q4 24
1.73×
Q3 24
0.70×
Q2 24
-0.43×
Q1 24
1.98×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CURI
CURI

Segment breakdown not available.

PKE
PKE

North America$16.8M97%
Other$546.0K3%

Related Comparisons